Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) dropped 8.8% during trading on Tuesday . The company traded as low as C$0.16 and last traded at C$0.16. Approximately 172,268 shares were traded during trading, a decline of 41% from the average daily volume of 289,881 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The company has a market capitalization of C$25.14 million, a P/E ratio of -4.79 and a beta of 0.39. The firm’s fifty day moving average is C$0.10 and its 200 day moving average is C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- What Do S&P 500 Stocks Tell Investors About the Market?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Capture the Benefits of Dividend Increases
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Are Treasury Bonds?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
